CNS Pharmaceuticals Inc

NEW
FRA:BE50 (USA)   Ordinary Shares
€ 0.61 (0%) Jul 21
At Loss
P/B:
62.39
Market Cap:
€ 7.03M ($ 8.02M)
Enterprise V:
€ 4.65M ($ 5.30M)
Volume:
0
Avg Vol (2M):
0
Trade In:

CNS Pharmaceuticals Inc Valuation Measures